Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

7.82
+0.10501.36%
Volume:587.30K
Turnover:4.61M
Market Cap:1.42B
PE:-76.62
High:7.99
Open:7.80
Low:7.78
Close:7.71
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:1.51
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-146.38
PE(LYR):2,436.86

Loading ...

Xeris Biopharma - to Retire $23 Mln Principal of Notes for $23 Mln Cash and Shares

THOMSON REUTERS
·
Jun 11

Savara COO Robert Lutz to take CFO role as Lowrance steps down for health reasons

Reuters
·
Jun 09

Xeris Biopharma director Marla Persky sells 15,500 shares worth $91,433.95

Reuters
·
Jun 06

Xeris Biopharma director Barbara-Jean Anne Bormann-Kennedy sells 16,000 shares for $97,507.2

Reuters
·
Jun 06

Xeris Biopharma director John Johnson sells 15,000 shares worth $91,422

Reuters
·
Jun 06

Xeris Biopharma Chief Legal Officer Beth Hecht sells 16,667 shares for $100,980.82

Reuters
·
Jun 03

Xeris Pharmaceuticals (XERS) Receives a Buy from Barclays

TIPRANKS
·
May 14

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Profit Turnaround And Guidance Hike

Simply Wall St.
·
May 11

Oppenheimer Sticks to Its Buy Rating for Xeris Pharmaceuticals (XERS)

TIPRANKS
·
May 08

Stock Track | Xeris Pharmaceuticals Soars 5.02% in Pre-market on Strong Q1 Results and Raised Guidance

Stock Track
·
May 07

GUIDANCE: (XERS) Xeris Biopharma Expects 2026 Revenue Range $380M - $390M, vs. FactSet Est of $383.3M

MT Newswires Live
·
May 07

Earnings Flash (XERS) Xeris Biopharma Holdings Posts Q1 EPS $0.01, vs. FactSet Est of $0.01 Loss per Share

MT Newswires Live
·
May 07

Xeris Biopharma Holdings Q1 EPS $0.01 Beats $(0.00) Estimate, Sales $83.127M Beat $79.992M Estimate

Benzinga Earnings
·
May 07

BRIEF-Xeris Biopharma Q1 Net Income USD 2.234 Million

Reuters
·
May 07

Xeris Biopharma Holdings Inc - Tightens FY2026 Total Revenue Guidance to $380 Mln-$390 Mln

THOMSON REUTERS
·
May 07

Xeris Biopharma Q1 EPS USD 0.01

THOMSON REUTERS
·
May 07

Xeris Biopharma CLO Beth Hecht disposes 16,667 shares for $103,804.31

Reuters
·
May 02

Earning Preview: Xeris Pharmaceuticals Inc revenue is expected to increase by 38.85%, and institutional views are cautiously optimistic

Earnings Agent
·
Apr 30

Xeris Biopharma to report first-quarter results, host conference call

Reuters
·
Apr 23

Xeris Biopharma director Jeffrey Sherman to retire from board

Reuters
·
Apr 22